Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Crizotinib for Treating Severe Neurofibromatosis Type 2 in Children Not Eligible for Surgery or Radiotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Imaging Study with 89Zr-Bevacizumab for Predicting Treatment Effects in Patients with NF2-Related Schwannomatosis

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • A study of mirdametinib for infants and toddlers under 24 months of age with neurofibromatosis type 1 associated plexiform neurofibromas

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Germany Spain
  • Study on Trametinib for Patients with Neurofibromatosis Type 1 and Symptomatic Plexiform Neurofibromas

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on the Effect of Food on Selumetinib in Adolescents with Neurofibromatosis Type 1 Plexiform Neurofibromas

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on Selumetinib for Children Aged 1 to 6 with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Spain
  • Study on Selumetinib for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Spain